- Home
- BKSY vs ACTU Comparison
BKSY vs ACTU Comparison
Compare BKSY & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- ACTU
- Stock Information
- Founded
- BKSY 2013
- ACTU 2015
- Country
- BKSY United States
- ACTU United States
- Employees
- BKSY N/A
- ACTU N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- ACTU
- Sector
- BKSY Technology
- ACTU
- Exchange
- BKSY Nasdaq
- ACTU NYSE
- Market Cap
- BKSY 157.7M
- ACTU 135.0M
- IPO Year
- BKSY N/A
- ACTU 2024
- Fundamental
- Price
- BKSY $14.21
- ACTU $7.47
- Analyst Decision
- BKSY Strong Buy
- ACTU Strong Buy
- Analyst Count
- BKSY 6
- ACTU 1
- Target Price
- BKSY $20.33
- ACTU $20.00
- AVG Volume (30 Days)
- BKSY 1.4M
- ACTU 88.2K
- Earning Date
- BKSY 08-07-2025
- ACTU 05-15-2025
- Dividend Yield
- BKSY N/A
- ACTU N/A
- EPS Growth
- BKSY N/A
- ACTU N/A
- EPS
- BKSY N/A
- ACTU N/A
- Revenue
- BKSY $107,401,000.00
- ACTU N/A
- Revenue This Year
- BKSY $31.61
- ACTU N/A
- Revenue Next Year
- BKSY $27.90
- ACTU N/A
- P/E Ratio
- BKSY N/A
- ACTU N/A
- Revenue Growth
- BKSY 7.05
- ACTU N/A
- 52 Week Low
- BKSY $3.86
- ACTU $5.51
- 52 Week High
- BKSY $21.92
- ACTU $11.99
- Technical
- Relative Strength Index (RSI)
- BKSY 69.62
- ACTU N/A
- Support Level
- BKSY $10.80
- ACTU N/A
- Resistance Level
- BKSY $13.34
- ACTU N/A
- Average True Range (ATR)
- BKSY 0.90
- ACTU 0.00
- MACD
- BKSY 0.06
- ACTU 0.00
- Stochastic Oscillator
- BKSY 87.48
- ACTU 0.00
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.